Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors.

Ala Y, Morin D, Mahé E, Cotte N, Mouillac B, Jard S, Barberis C, Tribollet E, Dreifuss JJ, Sawyer WH, Wo NC, Chan WY, Kolodziejczyk AS, Cheng LL, Manning M.

Eur J Pharmacol. 1997 Jul 23;331(2-3):285-93.

PMID:
9274991
2.

Position three in vasopressin antagonist tolerates conformationally restricted and aromatic amino acid substitutions: a striking contrast with vasopressin agonists.

Manning M, Cheng LL, Stoev S, Klis W, Nawrocka E, Olma A, Sawyer WH, Wo NC, Chan WY.

J Pept Sci. 1997 Jan-Feb;3(1):31-46.

PMID:
9230469
3.
4.

Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.

Manning M, Stoev S, Bankowski K, Misicka A, Lammek B, Wo NC, Sawyer WH.

J Med Chem. 1992 Jan 24;35(2):382-8.

PMID:
1531076
5.

Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors.

Barbeis C, Balestre MN, Jard S, Tribollet E, Arsenijevic Y, Dreifuss JJ, Bankowski K, Manning M, Chan WY, Schlosser SS, et al.

Neuroendocrinology. 1995 Aug;62(2):135-46.

PMID:
8584113
7.

Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.

Manning M, Cheng LL, Klis WA, Balaspiri L, Olma A, Sawyer WH, Wo NC, Chan WY.

J Med Chem. 1995 May 12;38(10):1762-9.

PMID:
7752199
8.

125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligand.

Elands J, Barberis C, Jard S, Lammek B, Manning M, Sawyer WH, de Kloet ER.

FEBS Lett. 1988 Mar 14;229(2):251-5.

9.

Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids.

Manning M, Przybylski J, Grzonka Z, Nawrocka E, Lammek B, Misicka A, Cheng LL, Chan WY, Wo NC, Sawyer WH.

J Med Chem. 1992 Oct 16;35(21):3895-904.

PMID:
1433200
10.

A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors.

Schmidt A, Audigier S, Barberis C, Jard S, Manning M, Kolodziejczyk AS, Sawyer WH.

FEBS Lett. 1991 Apr 22;282(1):77-81.

11.

Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.

Ammar A, Roseau S, Butlen D.

Am J Physiol. 1992 Apr;262(4 Pt 2):F546-53.

PMID:
1533099
12.

Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.

Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):63-9.

PMID:
9459574
13.

Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells.

Serradeil-Le Gal C, Bourrié B, Raufaste D, Carayon P, Garcia C, Maffrand JP, Le Fur G, Casellas P.

Biochem Pharmacol. 1994 Feb 11;47(4):633-41.

PMID:
8129742
14.
15.

Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.

Manning M, Kruszynski M, Bankowski K, Olma A, Lammek B, Cheng LL, Klis WA, Seto J, Haldar J, Sawyer WH.

J Med Chem. 1989 Feb;32(2):382-91.

PMID:
2913298
17.

Vasopressin and oxytocin receptors coupled to Ca2+ mobilization in rat inner medullary collecting duct.

Maeda Y, Han JS, Gibson CC, Knepper MA.

Am J Physiol. 1993 Jul;265(1 Pt 2):F15-25.

PMID:
8393622
18.

Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.

Manning M, Lammek B, Kolodziejczyk AM, Seto J, Sawyer WH.

J Med Chem. 1981 Jun;24(6):701-6.

PMID:
7252979
19.

V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.

Champigneulle A, Siga E, Vassent G, Imbert-Teboul M.

Am J Physiol. 1993 Jul;265(1 Pt 2):F35-45.

PMID:
8342613
20.

[125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors.

Kelly JM, Abrahams JM, Phillips PA, Mendelsohn FA, Grzonka Z, Johnston CI.

J Recept Res. 1989;9(1):27-41.

PMID:
2521670

Supplemental Content

Support Center